Ruxolitinib and DNA methyltransferase-inhibitors: A foray into combination regimens in myelofibrosis

Naval Daver; Srdan Verstovsek

doi:10.3109/10428194.2014.931955

Ruxolitinib and DNA methyltransferase-inhibitors: A foray into combination regimens in myelofibrosis

Naval Daver, Srdan Verstovsek

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	279-280
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	56
Issue number	2
DOIs	https://doi.org/10.3109/10428194.2014.931955
State	Published - Feb 1 2015

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2014.931955

Cite this

@article{834691c82c5141f8916860cc56c18721,

title = "Ruxolitinib and DNA methyltransferase-inhibitors: A foray into combination regimens in myelofibrosis",

author = "Naval Daver and Srdan Verstovsek",

year = "2015",

month = feb,

day = "1",

doi = "10.3109/10428194.2014.931955",

language = "English (US)",

volume = "56",

pages = "279--280",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - Ruxolitinib and DNA methyltransferase-inhibitors

T2 - A foray into combination regimens in myelofibrosis

AU - Daver, Naval

AU - Verstovsek, Srdan

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84923912538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923912538&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.931955

DO - 10.3109/10428194.2014.931955

M3 - Comment/debate

C2 - 24913500

AN - SCOPUS:84923912538

SN - 1042-8194

VL - 56

SP - 279

EP - 280

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -

Ruxolitinib and DNA methyltransferase-inhibitors: A foray into combination regimens in myelofibrosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this